MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
Publication
, Journal Article
Bleeker, G; van Eck-Smit, BL; Zwinderman, KH; Versteeg, R; van Noesel, MM; Kam, BL; Kaspers, GJ; van Schie, A; Kreissman, SG; Yanik, G; Hero, B ...
Published in: European Journal of Nuclear Medicine and Molecular Imaging
February 1, 2015
Purpose: The aim of this study was to find clinically relevant MIBG-avid metastatic patterns in patients with newly diagnosed stage 4 neuroblastoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
European Journal of Nuclear Medicine and Molecular Imaging
DOI
EISSN
1619-7089
ISSN
1619-7070
Publication Date
February 1, 2015
Volume
42
Issue
2
Start / End Page
222 / 230
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bleeker, G., van Eck-Smit, B. L., Zwinderman, K. H., Versteeg, R., van Noesel, M. M., Kam, B. L., … Tytgat, G. A. (2015). MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 222–230. https://doi.org/10.1007/s00259-014-2909-1
Bleeker, G., B. L. van Eck-Smit, K. H. Zwinderman, R. Versteeg, M. M. van Noesel, B. L. Kam, G. J. Kaspers, et al. “MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.” European Journal of Nuclear Medicine and Molecular Imaging 42, no. 2 (February 1, 2015): 222–30. https://doi.org/10.1007/s00259-014-2909-1.
Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, et al. MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. European Journal of Nuclear Medicine and Molecular Imaging. 2015 Feb 1;42(2):222–30.
Bleeker, G., et al. “MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 2, Feb. 2015, pp. 222–30. Scopus, doi:10.1007/s00259-014-2909-1.
Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Øra I, Schulte JH, Caron HN, Tytgat GA. MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. European Journal of Nuclear Medicine and Molecular Imaging. 2015 Feb 1;42(2):222–230.
Published In
European Journal of Nuclear Medicine and Molecular Imaging
DOI
EISSN
1619-7089
ISSN
1619-7070
Publication Date
February 1, 2015
Volume
42
Issue
2
Start / End Page
222 / 230
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 0299 Other Physical Sciences